Loqtorzi 240 MG/6 ML vial 6ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQS7Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,725
Award facts
- Contract value 100% obligated
- $19,724.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,724.79 to AmerisourceBergen Drug Corp for the supply of Loqtorzi 240 mg/6 mL vials on December 22, 2025, with an ultimate completion date of January 14, 2026. This non-set-aside, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Loqtorzi (ioflupane I-123) is a diagnostic radiopharmaceutical used in nuclear imaging to evaluate movement disorders and neurodegenerative conditions, supporting the medical needs of the military healthcare system and other federal customers.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in fulfilling federal medical procurement requirements through competitive awards across a comprehensive portfolio of pharmaceutical products and medical supplies. The company's SPE2DX master contract serves as a global pharmaceutical support vehicle enabling supply of medications, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the company's role as a critical vendor for specialized pharmaceutical products within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQS7Y?
SPE2DR26FQS7Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FQS7Y worth?
The government has obligated $19,725 on SPE2DR26FQS7Y.
Is contract SPE2DR26FQS7Y an order under another contract?
Yes. SPE2DR26FQS7Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS7Y competed?
The extent of competition for SPE2DR26FQS7Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award